About
Scott Byrd is an Entrepreneur-in-Residence at Frazier Life Sciences, which he joined in May 2020, and has more than 25 years of pharmaceutical industry experience. He was previously CEO of Outpost Medicine and President and COO of Acacia Pharma, Inc., and earlier served as SVP and Chief Commercial Officer of Cadence Pharmaceuticals, where he led the launch of OFIRMEV. He began his career in a range of roles at Eli Lilly and holds a B.S. in mechanical engineering from Bradley University and an M.B.A. from Harvard Business School.
Invests in
Biotech
Experience
- Sudo BiosciencesChief Executive Officercurrent2021 — present
- Frazier Life SciencesEntrepreneur In Residencecurrent2020 — present
- AlgoTxBoard Member2021 — 2025Paris, France
- ACACIA PHARMA GROUP LIMITEDChairman Of The Board2020 — 2022Greater Cambridge Area
- Outpost MedicinePresident & CEO2017 — 2021Greater Indianapolis
- Acacia Pharma Inc.COO, President - Acacia Pharma Inc.2015 — 2017Greater Indianapolis
- SAB Strategic Advisors LLCPresident, CEO2014 — 2015
- Cadence PharmaceuticalsSVP, Chief Commercial Officer2009 — 2014
- Eli Lilly and CompanyUS and Global Brand Leader - Cardiovascular and Critical Care1992 — 2009
Education
- Harvard Business SchoolMBA
- Bradley UniversityBSME, Mechanical Engineering
Skills & more
Pharmaceutical Sales61Marketing Strategy8Hospital Sales30Infectious Diseases11FinanceCritical Care1Product Launch26Commercialization19Oncology14Global Marketing9Medical Devices11Biotechnology33
+12 more
Cross-functional Team LeadershipSales EffectivenessMarket AccessDiabetesCardiologyClinical DevelopmentCompetitive IntelligenceBrand ManagementStrategyLeadershipPharmaceutical IndustryMarket ResearchFrom Scott's professional profile.
Same school
Also attended Harvard Business School1,777
Brad GerstnerFounder & CEO of Altimeter CapitalAileen LeeFounder & Managing Partner of Cowboy VenturesJim BreyerFounder & CEO of Breyer CapitalTim DraperFounder of Draper AssociatesMike Maples JrCo-founding Partner at FloodgateMamoon HamidPartner at Kleiner Perkins
+ 1,771 more
Also attended Bradley University5
Brent HillManaging Partner at Origin VenturesMark GrosshansPrincipal, Financial Performance at FrontenacBob DiMeoAdvisor — Chairman & Co-founder of Fiducient Advisors at Distributed VenturesTim SpihlmanManaging Director at Lewis & Clark VenturesDarcy AndersonSenior Strategist of Business and Communications at A-Rod Corp
Shared employers
Also worked at Sudo Biosciences3
Also worked at Frazier Life Sciences46
Patrick HeronManaging Partner at Frazier Life SciencesDaniel EstesGeneral Partner at Frazier Life SciencesJames W. BrushGeneral Partner and Portfolio Manager at Frazier Life SciencesAnna H. ChenPartner at Frazier Life SciencesGordon EmpeyCOO, Partner and General Counsel at Frazier Life SciencesKevin LiPrincipal at Frazier Life Sciences
+ 40 more
Also worked at Eli Lilly and Company69
David MollerInvestor at Third Rock VenturesJesper GromadaInvestor at Third Rock VenturesMark LevinRetired Founding Partner at Third Rock VenturesRhonda PachecoPresident, U.S. Business Unit and U.S. Country Head at Takeda VenturesCarlos PayaVenture Partner at Ysios CapitalKjersti FrognerInvestor at Almi Invest
+ 63 more
Investments
Board seats
Acacia Pharma Group plc
Per the firm's website.
Colleagues at Frazier Life Sciences
Adam Simpson
Venture Partner at Frazier Life Sciences
Aditya Kohli
Partner at Frazier Life Sciences
Alan Frazier
Chairman Emeritus at Frazier Life Sciences
Albert Cha
Managing Partner at Frazier Life Sciences
Ali Jackson
Vice President and Counsel, Public Funds at Frazier Life Sciences
Amanda Wilson
Senior Tax Manager at Frazier Life Sciences
Angel Martin
Senior Associate at Frazier Life Sciences
Angie You
Senior Advisor at Frazier Life Sciences